Lilly Diabetes & Me

Whether you or your child has just been diagnosed with type 1 diabetes or you've been managing it for years, Lilly is dedicated to providing you with information about Lilly innovation, resources and support as you continue this journey.

Throughout the year, we’ll send you emails filled with information about Lilly innovation, Disney recipes, and ways to become engaged in your local T1D community.

For those under 9

For those 10 to 17

For 18 and up

Let’s Get Started

Example: example@example.com

By providing my mobile phone number and submitting this form, I agree to receive automated calls and texts about Lilly Diabetes programs, and I understand that no purchase is necessary to receive calls or texts.

Which insulin(s) do you or your child take? (optional)

Having trouble registering? Call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).

The services provided by this Program include disease state information and/or information about Lilly Diabetes products as well as future Lilly Diabetes product updates and activities. This information will be sent to you through email and/or text to support your journey with Diabetes. When you click ‘Submit’ you certify that you are at least 18 years of age and a US resident, consent to use of your personal information, for Lilly and its agents to use, disclose, and/or transfer the personal information you supply to provide support related to your condition and treatment to administer this program, to analyze and/or measure program performance and program effectiveness for future enhancements, to personalize and improve your experience, including creating a preference profile, which may use data previously provided to Lilly for your participation in various other Lilly programs, and agree to receive requests for feedback on your experience with the related products, offerings, and program, requests to participate in market research and/or medical research.

For more information about Lilly’s privacy practice, please view the Lilly PRIVACY STATEMENT.